Engineering the Future
of Value.

From protocol assumptions to an approved, auditable supply plan.

Investigational medicinal product (IMP) supply planning has long lived in manually maintained planning files — demand curves, depot coverage, and resupply decisions held together by expert hands, hard to audit and slow to re-forecast. ClinSupplyCompass brings that discipline onto a purpose-built platform: study demand forecast from enrollment and dosing assumptions, depot-level supply coverage, an approved baseline, actuals loaded as the study runs, and controlled re-plans — with demand output ready for downstream procurement and distribution systems.

• Study-level demand forecasting from enrollment, dosing, and patient-retention assumptions — parallel, crossover, titration, and multi-country designs
• Depot-level inventory projection with months-of-supply and forward-coverage visibility
• Approved baselines, plan-versus-actual variance, and per-cycle supply KPIs
• Controlled re-forecasting for enrollment shifts and patient discontinuation, fully audited
• Secure multi-tenant delivery with organization-level isolation and AI-assisted study insight

The Planning Cycle

1. 01

   Forecast

   Study demand, depot inventory, and months-of-supply coverage

2. 02

   Approve Baseline

   Lock the supply plan the study team commits to

3. 03

   Load Actuals

   Enrollment, on-hand inventory, and receipts as the study runs

4. 04

   KPI Snapshot

   Variance and shortage risk against the approved baseline

5. 05

   Re-plan

   Controlled re-forecast when enrollment or retention shifts

A closed-loop planning cycle — the forecast learns from actuals, and every decision carries its audit trail. Live and available for sponsors, CROs, and clinical supply teams to explore.